Home » AGEB Journal » Issues » Volume 81" » Fasc.4 - Case series » Article details

Is propofol the optimal sedative in gastrointestinal endoscopy?

Journal Volume 81 - 2018
Issue Fasc.4 - Case series
Author(s) D. Stogiannou, A. Protopapas, A. Protopapas, K. Tziomalos
Full article
Full Article
VIEW FREE PDF
First Propedeutic Department of Internal Medicine, Medical School, Aristotle University of Thessaloniki, AHEPA Hospital, Thessaloniki, Greece.

Propofol is a sedative agent commonly used for sedation in gastrointestinal endoscopy. Its pharmacologic properties render propofol an almost ideal drug to achieve and maintain the targeted level of sedation in even complex gastrointestinal procedures. When compared with other sedative agents, propofol is associated with better patient and endoscopist satisfaction and shorter recovery times. Furthermore, propofol can be combined with other sedatives to reduce the total dosage required to achieve the targeted sedation. Its safety is demonstrated by multiple studies, in which adverse events occurred very rarely. Nevertheless, the use of propofol by non-anesthesiologists is illegal in many countries and in those permitted, a structured curriculum with clinical training must first be successfully completed. However, various studies have shown that non-anesthesiologist administration of propofol is comparable in efficacy and safety to administration by an anesthesiologist and more cost-effective. The results of numerous studies indicate that propofol is superior in many aspects compared with traditional sedative agents. (Acta gastroenterol. belg., 2018, 81, 520-524).

© Acta Gastro-Enterologica Belgica.
PMID 30645922